OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Updates in Oncology Pharmacy: Lu-177
14 minutes
Posted Jan 26, 2018 at 9:00 pm.
0:00
14:37
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
New Drug Approval: Lutetium-177-dotatate is discussed as well as updates to indications for denosumab (m. myeloma), afatinib, & olaparib.
Previous
Landmarks in Oncology Pharmacy: MOPP
Next
Foundations in Oncology Pharmacy: Doxorubicin
← See all 441 episodes of OncoPharm